Legacy MDM suffered from poor performance and usability.
Multiple legacy platforms led to poor usability.
Users complained of poor performance and data latency—merging records took up to an hour for one record.
Loss of user trust in data.
Many offline processes, scattered data, and lack of governance resulted in user mistrust of data.
Lack of affiliation management.
Inability to see complex relationships between HCOs and HCPs to better market to potential customers.
Data not readily consumable or trusted by users.
Cumbersome, inflexible search capabilities made it difficult for users to find the right data when needed.
Why AbbVie chose our platform.
Replacement of aging legacy systems to enhance data consumer experience with a modern UI, high performance, and improved data governance—and robust features such as affiliation management.
AbbVie's solution.
Replacement of legacy systems with modern data management.
Modernizing the landscape and ensuring high performance with Reltio as the center of their consumption and integration hubs.
Scalable cloud-native platform.
Having a modern, scalable platform enabled them to handle acquisitions such as Allergan, which almost doubled their size.
Integration with CRMs and more.
Connected AbbVie’s CRMs, data lakes, data warehouses such as Snowflake, and more with our Reltio platform at the center.
Enhanced data governance and quality.
Implemented data governance rules and processes to boost user trust in data and simplify regulatory compliance.